
Alpha Teknova, Inc.
92
Recent developments include Alpha Teknova's Q3 2026 earnings call and financial results, a public offering, product innovation, and updates on financial performance and guidance.
- Alpha Teknova reported third quarter 2026 revenue of $12.7 million and raised revenue guidance to $46-48 million [N3].
- The company reported a net loss for Q3 2026 but topped revenue expectations [N4].
- Alpha Teknova entered an underwriting agreement for an 8 million share public offering and priced a $40 million offering at $5 per share in October 2026 [N5][N6].
- Teknova unveiled Fill-Tek, a product for customized single-use reagent orders, indicating ongoing innovation [N7].
- The company held its Q3 2026 earnings call providing detailed financial and operational updates [N1][N2].
- Alpha Teknova's Q4 loss decreased as reported earlier in 2026 [N8].
Alpha Teknova, Inc. operates as a publicly traded company listed on Nasdaq under the ticker TKNO. The company engages in manufacturing and supplying specialized products, including customized single-use reagents, as evidenced by its Fill-Tek product launch. Financial disclosures indicate ongoing investment in growth and product development. The company maintains liquidity with current assets significantly exceeding current liabilities and has raised capital through a recent public offering. Alpha Teknova regularly communicates financial results and business updates through quarterly earnings calls and SEC filings, providing transparency into its operations and financial condition.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Alpha Teknova, Inc. reported third quarter 2026 revenue of $12.7 million and raised revenue guidance to $46-48 million. The company reported a net loss of $3.49 million for Q3 2026 with EPS of -$0.06. Teknova completed a $40 million public offering in October 2026 and continues product innovation with offerings such as Fill-Tek for customized reagent orders. The company maintains strong liquidity with a current ratio of 3.56 as of September 30, 2026 [N3][N5][N6][N7][S2].
The company demonstrates business momentum through revenue growth and raised guidance, supported by successful capital raises and product innovation. Its liquidity position provides operational flexibility. Continued execution on product development and market expansion could enhance its business profile.
Alpha Teknova reports ongoing net losses and negative earnings per share, indicating challenges in achieving profitability. The company faces risks related to market conditions, regulatory environment, competition, and supply chain stability as disclosed in SEC filings. Dependence on capital markets for funding and execution risks in product commercialization present potential challenges.
Alpha Teknova's moat appears to be based on its specialized product offerings such as customized single-use reagents and its ability to innovate within its niche market. The company's ongoing product development and collaborations, combined with its public market presence and capital raising capabilities, contribute to its competitive positioning. However, detailed information on intellectual property or barriers to entry is not explicitly disclosed in the available data.
• Market and Economic Conditions: General economic and market conditions may impact customer demand for the company's products.
• Financial Performance and Profitability: The company has a recent history of losses and negative earnings per share, which may affect its financial sustainability.
• Regulatory and Compliance Risks: Regulatory developments in the U.S. and other countries could impact operations and product approvals.
• Competition and Technology Risks: Increased competition and availability of advanced technologies may affect market share and product relevance.
• Supply Chain and Operational Risks: Challenges in securing stable raw material supplies and operational execution could disrupt business activities.
• Capital and Liquidity Risks: Dependence on equity offerings and capital markets to fund operations introduces financing risk.
Business trends: Revenue growth with raised guidance and ongoing product innovation highlight active business development.
Execution milestones: Completion of a $40 million public offering, launch of Fill-Tek product, and regular earnings disclosures demonstrate execution progress.
Key risks: Continued net losses, reliance on capital markets, regulatory uncertainties, and operational challenges including supply chain and competition risks.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Alpha Teknova, Inc. is a publicly traded company on Nasdaq under the ticker TKNO [S2].
- As of September 30, 2026, the company had cash and cash equivalents of $6.63 million and current assets of $31.8 million, with current liabilities of $8.93 million, resulting in a current ratio of 3.56 and a cash ratio of 0.74 [S2].
- The company reported a net loss of $3.49 million for the quarter ended September 30, 2026, with basic and diluted EPS of -$0.06 per share [S2].
- Alpha Teknova reported third quarter 2026 revenue of $12.7 million and raised its revenue guidance to a range of $46-48 million [N3].
- The company entered an underwriting agreement for an 8 million share public offering and priced a $40 million public offering at $5 per share in October 2026 [N5][N6].
- Teknova unveiled Fill-Tek, a product for customized single-use reagent orders, indicating ongoing product innovation [N7].
- The company has a history of quarterly earnings calls and financial disclosures, including Q3 2026 and prior quarters, providing transparency into financial performance and business developments [N1][N2][N4][N8][S1][S2].
- Alpha Teknova is classified as a non-accelerated filer, smaller reporting company, and emerging growth company as of the latest filings [S2].
- The company cautions about various risks including market conditions, regulatory developments, competition, supply chain stability, and operational challenges as disclosed in its SEC filings [S1][S2].
Generated 2026-11-08
- S1 | 2026-03-02 | 10-K
- S2 | 2026-11-05 | 10-Q
- N1 | 2026-11-05 | www.nasdaq.com | Alpha Teknova (TKNO) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/alpha-teknova-tkno-q3-2026-earnings-call-transcript
- N2 | 2026-11-05 | www.nasdaq.com | Alpha Teknova Q3 Earnings Call Highlights | https://www.nasdaq.com/articles/alpha-teknova-q3-earnings-call-highlights
- N3 | 2026-11-05 | www.nasdaq.com | Alpha Teknova, Inc. Reports Third Quarter 2026 Revenue of $12.7 million and Raises Revenue Guidance to $46-48 million | https://www.nasdaq.com/articles/alpha-teknova-inc-reports-third-quarter-2026-revenue-127-million-and-raises-revenue
- N4 | 2026-11-04 | www.nasdaq.com | Alpha Teknova (TKNO) Reports Q3 Loss, Tops Revenue Estimates | https://www.nasdaq.com/articles/alpha-teknova-tkno-reports-q3-loss-tops-revenue-estimates
- N5 | 2026-10-22 | www.nasdaq.com | Alpha Teknova, Inc. Enters Underwriting Agreement for 8,000,000 Share Public Offering and Announces Preliminary Financial Estimates for the Three Months Ended September 30, 2026 | https://www.nasdaq.com/articles/alpha-teknova-inc-enters-underwriting-agreement-8000000-share-public-offering-and
- N6 | 2026-10-21 | www.nasdaq.com | Teknova Prices $40 Mln Public Offering At $5 Per Share | https://www.nasdaq.com/articles/teknova-prices-40-mln-public-offering-5-share
- N7 | 2026-09-17 | www.nasdaq.com | Teknova Unveils Fill-Tek For Customized Single-Use Reagent Orders | https://www.nasdaq.com/articles/teknova-unveils-fill-tek-customized-single-use-reagent-orders
- N8 | 2026-02-27 | www.nasdaq.com | Alpha Teknova, Inc. Q4 Loss Decreases | https://www.nasdaq.com/articles/alpha-teknova-inc-q4-loss-decreases
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


